Condition: Moyamoya Disease · Sponsor: Beijing Tiantan Hospital
The purpose of this study is to comprehensively evaluate the risk factors for cognitive decline in patients with moyamoya disease, identify imaging target areas associated with cognitive damage in the brain, and explore the changes in brain structure and functional networks resulting from cerebral revascularization, as well as their relationship with cognitive improvement.
This description comes directly from the study's public registry record.
Qian Zhang, MD · 8613120012579 · zhangqianchina@yahoo.com
Chaofan Zeng, MD · 8613693276138 · zchf723@163.com
Always discuss trial participation with your own doctor first.
| Beijing Tiantan Hospital | Beijing, China, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06832839